Our Clinical Operations (multi-sponsor) department in the UK is looking for a CRA II to work across a variety of therapeutic areas – including Oncology. You can be based anywhere in the UK but we do need previous UK monitoring experience.
The role in summary:
• National monitoring across the UK
• Oncology trials will include various solid tumor studies, Prostate, NSCLC, Leukemia, Breast, Glioblastoma and studies in Hematological Malignancies
• Other TAs include Neuroscience, Cell/Gene therapies, Respiratory, Cardiovascular, Infectious disease, Nephrology, Endocrinology & Gastroenterology
• On average each CRA will work across 5 protocols or more
• Risk based monitoring model
• 8 days on site per month or more
Join a fast-paced global CRO that combines innovation with 30 years of expertise, offering personalized development plans and career progression. Work in a supportive environment with flexible Line Managers, gain diverse experience through collaborations with smaller biotech and biopharma pioneers and contribute to cutting-edge therapies.
Learn more about our EEO & Accommodations request here.
What We Do
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network.
Our talented and diverse team working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.
